HeartBeam, Inc.

Aktienanalyse zu HeartBeam, Inc. (BEAT)

$0.406

+0.011 (+2.74%)Zum Schluss

Loading chart…
Hoch
0.413
Eröffnung
0.395
Volumengewichteter Durchschnittskurs
0.40
Volumen
817.90K
Marktkap.
66.09M
Tief
0.382
Umsatz
327.05K
EV/EBITDA, TTM
0.00

HeartBeam, Inc. is a cardiac technology company. The Company focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. It is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. It is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.

www.heartbeam.com

KI-Analyse of HeartBeam, Inc. (BEAT)

Verkaufen

HeartBeam Inc. is not a good buy right now due to significant ongoing losses and a declining stock price. The current price is $0.41, which is 83.31% lower year-to-date. The RSI is at 39.643, indicating the stock is nearing oversold territory, but the negative sentiment and financial performance overshadow this. The company reported a net loss of $4.7 million in Q1 2026, and the forward P/E ratio is 0, indicating no earnings expected in the near future. The main risk is the high volatility, with a 5-day change of -26.27%.

Analystenbewertungen (7)

+1337.73% Aufwärtspotenzial
Kaufen
7 Kaufen
0 Halten
0 Verkaufen
Aktuell: 0.41
Tief
4.00
Durchschnitt
5.83
Hoch
8.00

H.C. Wainwright

2026-09-22

Kursziel

—

Neutral

Maxim

2026-07-14

Kursziel

$2

Kaufen

Benchmark

2026-05-15

Kursziel

$5

Speculative Buy

D. Boral Capital

2026-04-20

Kursziel

—

Halten

Roth Capital

2025-10-31

Kursziel

$4

Kaufen

Bewertungskennzahlen

Das aktuelle erwartete KGV von HeartBeam, Inc. (BEAT) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von -2.80.

Erwartetes KGV

Stark überbewertet
5J-Durchschnitt P/E
-2.80
Aktuelles P/E
0.00
Überbewertet
-1.46
Unterbewertet
-4.15

Erwartetes EV/EBITDA

Fair bewertet
5J-Durchschnitt EV/EBITDA
-0.14
Aktuelles EV/EBITDA
0.00
Überbewertet
0.44
Unterbewertet
-0.72

Erwartetes KUV

Fair bewertet
5J-Durchschnitt P/S
72.96
Aktuelles P/S
5.95
Überbewertet
333.41
Unterbewertet
-187.48

Alphio-AI-Kursszenarien für BEAT

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%BEAT

$1.70

Szenariopreis

B

Basis

Basis · 50%BEAT

$1.50

Szenariopreis

B

Bärisch

Bärisch · 25%BEAT

$1.28

Szenariopreis

Event-Zeitleiste

2026-11-02 (ET)

09:00:00

HeartBeam Announces Positive Results from ALIGN-ACS Study

2026-10-28 (ET)

09:31:00

HeartBeam to Present Heart Attack Study Results at TCT 2026

2026-10-26 (ET)

09:00:00

HeartBeam's 3D ECG Technology Accepted into FDA TAP Program

2026-10-05 (ET)

09:00:00

HeartBeam Receives FDA Breakthrough Device Designation

2026-09-21 (ET)

09:00:00

HeartBeam Clarifies Focus on Heart Attack Detection

News

BEAT FAQ – beantwortet von Alphio AI

HeartBeam, Inc. is a cardiac technology company. The Company focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. It is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. It is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

HeartBeam Inc. is not a good buy right now due to significant ongoing losses and a declining stock price. The current price is $0.41, which is 83.31% lower year-to-date. The RSI is at 39.643, indicating the stock is nearing oversold territory, but the negative sentiment and financial performance overshadow this. The company reported a net loss of $4.7 million in Q1 2026, and the forward P/E ratio is 0, indicating no earnings expected in the near future. The main risk is the high volatility, with a 5-day change of -26.27%.

7 analysts cover BEAT: 7 rate it Buy, 0 Hold and 0 Sell. The average price target is 5.83.

Community

Mehr ↗
cobaltfilamentvor 4 Std.

Good fortune and great times. Fish for dinner tonight. Brothers, it's time for dinner. $ETH $ZEC $AKE #USOctoberNonfarmPayrollsBeatExpectations, DecemberRateHikeBetsRise

Mehr anzeigen
HyperTradervor 10 Std.

500 Yuan Challenge to Reach 100 Million! Day 44 Principal 500 yuan, goal 100 million Current: 10,707 yuan Living costs: 5,000 yuan Available funds: 5,707 yuan The Big Devil 500-to-100-million live trading progress! First, the account: total assets 5,707.3 yuan, monthly return directly 81.1%, profit 2,873 yuan. This equity curve is really worth watching. It once peaked at 8,773, then heavily drawdown to 505, almost back to the initial principal. After enduring a wave of extreme shakeout, it walked back up again. This time I positioned two 10x short orders on $CAP and $BEAT, both showing unrealized gains. The CAP short was opened at 0.10358, unrealized gain close to 28%; the BEAT short was opened at 0.10839, unrealized gain nearly 50%. Margin is sufficient, and the safety distance is ample. Looking back at the chart, both are small-cap new coins. After an earlier surge, bullish momentum faded, overhead selling pressure kept releasing, and prices gradually pulled back, which fit our idea of testing shorts at highs. But the biggest feature of small-cap coins is that funds can push them up at any time, and a single big green candle can reverse everything, so I must not get carried away. The plan going forward is clear: don't be greedy. Move take-profit levels up and lock in part of the profit first. Focus on the overhead resistance. Once price holds above resistance, it means the short-term trend has reversed, so reduce the position and exit immediately. The challenge road is long. In such highly volatile coins, surviving first and protecting profit is what gives me the chance to slowly move toward 100 million! The 500 yuan challenge to reach 100 million was never about stable, effortless gains. It is a process of constant trial, review, and risk control. Don't get proud when profitable, summarize lessons when losing, strictly control leverage and position size, and move step by step toward the goal. $BTC #US October nonfarm payrolls beat expectations, December rate hike bets rise #US stocks rebound in tech after selloff, Nasdaq still down about 3.4% for the week #BTC and ETH spot ETFs see over $1.6 billion in net outflows for the week

Mehr anzeigen
rhocurrentvor 6 Tagen

I couldn't resist shorting $BEAT on the left side again, entered at 0.103. The hardest part of holding was when I was down -600u, price had risen to 0.11. Now it's a bit better, back to 0.104. Should I take the loss and exit, or keep holding?

Mehr anzeigen
CopperBaker31.10.2026

$BEAT Although the 17.63M BEAR unlock is happening tomorrow, I still wouldn't recommend holding a heavy position right now. Everyone knows the market maker tends to push the price up before an unlock to sell off. There was already a pump earlier, and many people assume it's a safe short here. But this kind of mid-range price action right before an unlock is the most dangerous. A bearish view is reasonable, but the biggest risk is a violent pump before the dump that squeezes out shorts and then drags longs down with it, letting them capture both sides. Not holding heavy is what keeps your position able to withstand a sharp pump from the market maker. If you want to be cautious, you can enter short in the early morning or on a bounce near 0.1-0.11. You can also enter at the current price of 0.096, but start light and keep room to add.

Mehr anzeigen
Registriere dich oder melde dich an, um mitzudiskutieren

Ähnliche Artikel

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln